Ubrelvy (ubrogepant) 100mg Tablet

Ubrelvy (ubrogepant) 100mg Tablet

Ubrelvy 100 mg Tablet is a prescription medicine used for the acute treatment of migraine attacks, with or without aura, in adults. Its active ingredient, Ubrogepant, belongs to a class of medicines called CGRP receptor antagonists. Unlike preventive migraine treatments, Ubrelvy is taken at the onset of a migraine attack to relieve symptoms such as headache pain, light sensitivity, and nausea.

Ubrelvy works by blocking the activity of the calcitonin gene-related peptide (CGRP), a protein involved in migraine attacks. By targeting this pathway, it provides fast and effective relief without the vasoconstrictive effects seen in older migraine medications like triptans. This makes it a valuable option for patients who cannot tolerate or do not respond to traditional migraine therapies.

The usual dose is one 100 mg tablet taken as soon as a migraine begins, with the possibility of a second dose after at least 2 hours if needed. Side effects are generally mild and may include sleepiness, nausea, or dry mouth.

Ubrelvy offers patients a safe and effective way to manage migraine attacks and restore quality of life.